Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3RPE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,341
Award facts
- Contract value 100% obligated
- $32,341.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $32K, was awarded on December 15, 2025, to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The Defense Logistics Agency (DLA), a defense-focused federal procurement entity, funded this competitive award, which represents a firm fixed-price contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 16, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Repatha (evolocumab) is a PCSK9 inhibitor used for cardiovascular disease management, particularly in patients with high cholesterol or those at significant risk for heart disease. AmerisourceBergen's role as a pharmaceutical distributor positions it to deliver specialized medications like this across the Defense Health Agency and military healthcare systems. The DLA Troop Support Medical contract vehicle demonstrates the agency's reliance on established vendor relationships to efficiently fulfill dynamic pharmaceutical needs across the federal healthcare system, with the company demonstrating capability to handle both routine and specialized medication procurement through competitive, firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26F3RPE?
SPE2DR26F3RPE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F3RPE worth?
The government has obligated $32,341 on SPE2DR26F3RPE.
Is contract SPE2DR26F3RPE an order under another contract?
Yes. SPE2DR26F3RPE is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3RPE competed?
The extent of competition for SPE2DR26F3RPE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award